838
Participants
Start Date
September 3, 2013
Primary Completion Date
February 26, 2018
Study Completion Date
April 5, 2019
Ibrutinib
560 mg capsules administered by mouth once daily (21-day cycles)
Placebo
4 matched capsules administered by mouth once daily (21-day cycles)
Rituximab
375 mg/m2 administered intravenously once on Day 1 of each cycle (21-day cycles)
Cyclophosphamide
750 mg/m2 administered intravenously once on Day 1 of each cycle (21-day cycles)
Doxorubicin
50 mg/m2 administered intravenously once on Day 1 of each cycle (21-day cycles)
Vincristine
1.4 mg/m2 administered intravenously once on Day 1 of each cycle (21-day cycles)
Prednisone (or equivalent)
100 mg capsules administered by mouth once daily on Day 1 to Day 5 of each cycle
Tucson
Greenbrae
La Jolla
Los Angeles
Salinas
Stanford
Danbury
Hartford
Washington D.C.
Atlanta
Marietta
Peoria
Fort Wayne
Goshen
Indianapolis
Topeka
Louisville
Baton Rouge
New Orleans
Baltimore
Bethesda
Boston
Ann Arbor
St Louis
Omaha
Hackensack
New Brunswick
Fresh Meadows
Johnson City
Mineola
New York
Rochester
The Bronx
Charlotte
Greenville
Hickory
Columbus
Portland
North Charleston
Nashville
Houston
Temple
Burlington
Seattle
Buenos Aires
Ciudad de Buenos Aires
Adelaide
Concord
Darlinghurst
Hobart
Melbourne
Nedlands
Perth
Randwick
South Brisbane
Woolloongabba
Antwerp
Bruges
Brussels
Ghent
Haine Saint Paul La Louviere
Kortrijk
Leuven
Porto Alegre
Rio de Janeiro
São Paulo
Edmonton
Vancouver
Halifax
Toronto
Lévis
Montreal
Beijing
Changchun
Chengdu
Guangzhou
Hangzhou
Harbin
Jinan
Nanjing
Shanghai
Tianjin
Brno
Hradec Králové
Ostrava
Prague
Aarhus N
Copenhagen
Roskilde
Vejle
Helsinki
Jyväskylä
Oulu
Turku
Grenoble
Limoges
Paris
Pessac
Pierre-Bénite
Rouen
Tours
Villejuif
Augsburg
Bamberg
Berlin
Dresden
Essen
Frankfurt
Jena
München
Münster
Villingen-Schwenningen
Budapest
Debrecen
Gyula
Szombathely
Veszprém
Beersheba
Hadera
Haifa
Petah Tikva
Ramat Gan
Tel Aviv
Fukuoka
Hiroshima
Isehara
Kobe
Kumamoto
Kyoto
Nagano
Nagoya
Narita
Osaka
Ōsaka-sayama
Sapporo
Sendai
Suita
Tachikawa
Tokyo
Tsukuba
México
Monterrey
San Luis Potosí City
Amsterdam-Zuidoost
Arnhem
Dordrecht
Groningen
Leiden
Nieuwegein
Rotterdam
Oslo
Tromsø
Brzozów
Chorzów
Krakow
Lodz
Olsztyn
Poznan
Warsaw
Wroclaw
Moscow
Nizhny Novgorod
Rostov-on-Don
Saint Petersburg
Sochi
Volgograd
Yekaterinburg
Busan
Goyang-si
Seoul
Barcelona
Madrid
Salamanca
Seville
Linköping
Luleå
Lund
Uppsala
Taichung
Tainan City
Taoyuan
Adana
Ankara
Istanbul
Izmir
Kayseri
Samsun
Cherkassy
Khmelnitskiy
Kiev
Lviv
Makiivka
Glasgow
Liverpool
London
Maidstone
Manchester
Nottingham
Oxford
Romford
Southampton
Collaborators (1)
Pharmacyclics LLC.
INDUSTRY
Janssen Research & Development, LLC
INDUSTRY